製品番号: HY-N11546

Sapindoside B

カスタマーレビュー

Based on 1 Customer Validation

Sapindoside B is a substance with hepatoprotective activity, and also acts as a cytochrome P-450 (cytochrome P-450) inhibitor, antibacterial agent and membrane-disrupting agent. Sapindoside B reversibly inhibits the content of cytochrome P-450 in liver microsomes, suppresses the phenobarbital-induced increase in enzyme content, reduces the production of active metabolites mediated by cytochrome P-450, and alleviates hepatotoxic injury. Sapindoside B binds to Cutibacterium acnes lipase, reduces lipase activity, inhibits biofilm formation, and decreases bacterial adhesion. Sapindoside B exhibits cytotoxicity against human cancer, liver cancer, leukemia and glioblastoma cells. Sapindoside B inhibits mycelial growth of phytopathogenic fungal strains, possesses antibacterial activity against dermatophytes, and also has hemolytic/membrane-lytic activity. Sapindoside B can be used in research related to liver injury, Cutibacterium acnes biofilm-associated infections, gastric cancer, carcinoma, promyelocytic leukemia, glioblastoma, apple scab and grape gray mold.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

純度: 96.68%
CAS 番号: 30994-75-3
分子式: C₄₆H₇₄O₁₆
分子量:883.07

保管条件:

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Sapindoside B 構造式

CAS 番号: 30994-75-3

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

Cytochrome P450 アイソフォーム固有の製品をすべて表示 :

体外実験

Sapindoside B (0.1MIC-0.5MIC; 3 d) dose-dependently inhibits early biofilm formation and mature biofilms of Cutibacterium acnes ATCC 6919 at sub-MIC concentrations, suppresses the adhesion of Cutibacterium acnes ATCC 6919, reduces cell surface hydrophobicity, decreases extracellular polysaccharide production in biofilms, inhibits lipase activity in biofilms, and disrupts the structure of early-formed biofilms^[3].
Sapindoside B (0.5MIC; 3 d) reduces the biomass, thickness and diffusion distance of early-formed Cutibacterium acnes ATCC 6919 biofilms, while increases their roughness. It downregulates the expression of biofilm-related genes^[3].
Sapindoside B (0.5-50 μM; 72 h) exhibits moderate cytotoxicity against human gastric cancer cells SGC-7901, human hepatocellular carcinoma cells HepG2, human promyelocytic leukemia cells HL-60, and human glioblastoma cells U251MG, with IC₅₀ values ranging from 4.24 μM to 15.37 μM^[4].
Sapindoside B (5 mg per 100 mL; treated for 21 days against *V. inaequalis* and 4 days against *B. cinerea*) inhibits mycelial growth of *Venturia inaequalis* V1 by 46% and mycelial growth of *Botrytis cinerea* B05.10 by 43% under in vitro conditions^[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay^[4]

Cell Line:

human gastric carcinoma SGC-7901 cells, human liver hepatoma HepG2 cells, human promyelocytic leukemia HL-60 cells, human glioblastoma U251MG cells
Concentration:

0.5, 2, 10, 50 μM
Incubation Time:

72 h
Result:

Exhibited cytotoxic activity against all four tested cancer cell lines, with IC₅₀ values of 10.32 μM for SGC-7901, 4.24 μM for HepG2, 6.58 μM for HL-60, and 15.37 μM for U251MG.

体内実験

Sapindoside B (20 mg/kg; s.c.; 2 or 3 times at 8-hour intervals) suppresses hepatic microsomal cytochrome P-450 content by 55-60% in healthy Kunming strain male mice^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Kunming (male, 20-24 g)^[1]
Dosage:

20 mg/kg
Administration:

s.c.; 2 or 3 times at 8-hour intervals
Result:

Reduced hepatic microsomal cytochrome P-450 content by 55%.
Reduced hepatic microsomal cytochrome P-450 content by 60%.

化学情報

CAS 番号 30994-75-3
性状 Solid
分子量 883.07
分子式 C₄₆H₇₄O₁₆
Color White to off-white
SMILES

C[C@@]12C([C@@]3([H])[C@@](CC2)(CCC(C)(C3)C)C(O)=O)=CC[C@@]4([H])[C@]1(CC[C@]5([H])[C@@]4(CC[C@@H]([C@@]5(C)CO)O[C@H]6[C@@H]([C@H]([C@H](CO6)O)O)O[C@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)C)O)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O)O)C)C
Structure Classification
- Terpenoids
- Diterpenoids
Initial Source
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (281 KB)
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Shi JZ, et al. Effect of alpha-hederin and sapindoside B on hepatic microsomal cytochrome P-450 in mice. Zhongguo yao li xue bao = Acta Pharmacologica Sinica. 1996 May;17(3):264-266.

[2]. Sawada H, et al. Saponins from leaves of Acanthopanax sieboldianus. Phytochemistry. 1993;34(4):1117-1121. [Content Brief]

[3]. Wei MP, et al. Synergistic combination of Sapindoside A and B: A novel antibiofilm agent against Cutibacterium acnes. Microbiol Res. 2022;254:126912. [Content Brief]

[4]. Zhao M, et al. Cytotoxic triterpenoid saponins from Clematis tangutica. Phytochemistry. 2016;130:228-237. [Content Brief]

[5]. Porsche FM, et al. Antifungal Activity of Saponins from the Fruit Pericarp of Sapindus mukorossi against Venturia inaequalis and Botrytis cinerea. Plant Dis. 2018;102(5):991-1000. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

Sapindoside B

Anti-Infection Compound Library

Metabolism/Protease Compound Library

Natural Product Library

Anti-Cancer Compound Library

Anti-Aging Compound Library

Antioxidant Compound Library

Oxygen Sensing Compound Library

Antifungal Compound Library

Antibacterial Compound Library

Medicine Food Homology Compound Library

Terpenoids Library

Traditional Chinese Medicine Active Compound Library

Anti-Blood Cancer Compound Library

Mitochondria-Targeted Compound Library

Anti-Liver Cancer Compound Library

Anti-Cancer Natural Product Library

Plant-Sourced Natural Product Library

Metabolic Enzyme Compound Library

Anti-Hematopathy Compound Library

Multi-Target Compound Library

Radioprotector Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Natural Product Library Plus

Natural Product and Natural Product-Like Compound Library

Bioactive Compound Library

Anti-Gastric Cancer Compound Library

Miao Ethnicity Medicine Compound Library

Heat-Clearing and Detoxification Traditional Chinese Medicine Compound Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Ancient Chinese Classical Formulas Traditional Chinese Medicine Active Compound Library

Antitussive and Antiasthmatic Traditional Chinese Medicine Active Compound Library

Diarrhea-Related Traditional Chinese Medicine Active Compound Library

Mass Spectrometry Natural Product Library

Cytochrome P450 アイソフォーム固有の製品をすべて表示

生物活性

化学情報

純度とドキュメンテーション

参考文献

Calculators

Help & FAQs

Sapindoside B 関連分類

HY-N11546 関連分類